Drug of Abuse Testing Services Market (By Drug Type: Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, LSD) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

The global drug of abuse testing services market size was estimated at around USD 6.55 billion in 2023 and it is projected to hit around USD 9.64 billion by 2033, growing at a CAGR of 3.94% from 2024 to 2033.

Key Pointers

• North America dominated the market with the largest market share of 53% in 2023.
• Asia Pacific is anticipated to grow at the noteworthy CAGR during the forecast period.
• By Drug Type, the Cannabis/Marijuana segment captured the maximum market share of 24% in 2023.
• By Drug Type, the opioids segment is forecasted to witness a significant compound annual growth rate (CAGR) from 2024 to 2033.

Drug of Abuse Testing Services Market Overview

The drug of abuse testing services market continues to witness significant growth driven by various factors such as the rising prevalence of substance abuse, stringent regulations mandating drug screening in workplaces, and advancements in testing technologies.

Drug of Abuse Testing Services Market Growth Factors

The growth of the drug of abuse testing services market is propelled by an escalating prevalence of substance abuse worldwide has significantly increased the demand for drug screening services across various sectors. Additionally, stringent regulations mandating drug testing in workplaces, sports organizations, and transportation sectors further drive market growth. Moreover, continuous advancements in testing technologies, such as the development of rapid testing kits and laboratory automation, play a crucial role in expanding the market. These factors collectively contribute to the sustained growth and evolution of the drug of abuse testing services market, highlighting its importance in addressing public health concerns related to substance abuse.

Drug of Abuse Testing Services Market Trends:

• Shift Towards Point-of-Care Testing: There is a noticeable trend towards the adoption of point-of-care testing solutions due to their convenience, rapid results, and cost-effectiveness. This trend is particularly significant in settings where immediate decision-making is crucial, such as emergency departments and roadside screenings.
• Rising Adoption of Drug Screening in Non-Workplace Settings: Drug testing services are increasingly being utilized in non-workplace settings, including schools, rehabilitation centers, and criminal justice systems. This trend is driven by the need for early intervention and rehabilitation programs to address substance abuse issues effectively.
• Integration of Advanced Technologies: The market is witnessing a rapid integration of advanced technologies, including immunoassays, chromatography, and mass spectrometry, to enhance the accuracy and reliability of drug testing services. Moreover, the emergence of novel biomarkers and testing methodologies is expected to further revolutionize the landscape of drug of abuse testing.

Drug Type Insights

The Cannabis/Marijuana segment held the largest revenue share of 24% in 2023, dominating the market. This dominance is attributed to the increased demand for marijuana testing, including both medical screening and employment testing. Additionally, the growing prevalence of cannabis/marijuana addiction has fueled the demand for these services. According to the World Health Organization (WHO), approximately 147 million people, which accounts for around 2.5% of the global population, consume cannabis annually, surpassing the consumption of opioids and cocaine. Consequently, the Cannabis/Marijuana segment is expected to experience a surge in demand, particularly for screening programs in criminal justice, treatment centers, workplaces, and clinical settings.

The opioids segment is forecasted to witness a significant compound annual growth rate (CAGR) from 2024 to 2033. The robust growth of this segment is primarily driven by the need for employment screening and monitoring prescription misuse. Opioid testing is predominantly conducted using a patient’s blood, hair, saliva, sweat, or urine samples. As opioid abuse continues to be a pressing concern, the demand for opioid testing services is expected to remain high, further contributing to market growth.

Regional Insights

North America emerged as the dominant market for drug of abuse testing services, capturing the largest revenue share of 53% in 2023. The region's supremacy is driven by various factors, including the expanding population vulnerable to addiction, escalating drug use in workplaces, a surge in accidents, and the presence of well-established healthcare facilities. Statistics from the National Council on Alcoholism & Drug Dependence (NCADD) reveal that 70% of the 14.8 million employed individuals in the United States are involved in drug abuse. Similarly, data from the National Drug-Free Workplace Alliance indicates that over 74% of current illegal drug users in the U.S. are employed, contributing to as much as 40% of industrial fatalities. Moreover, findings from the Ministry of Foreign Affairs, People's Republic of China, suggest that a significant percentage of U.S. drug users have experience with various substances, highlighting the pressing need for effective drug testing measures to ensure employee safety and well-being.

Asia Pacific is poised to exhibit the fastest growth in the drug of abuse testing services market during the forecast period. This rapid growth can be attributed to the persistent high levels of drug-related activities in Asian nations, coupled with stringent drug control policies. Additionally, the region benefits from developing healthcare infrastructure, enhanced drug intelligence exchange, strengthened law enforcement cooperation, anti-drug campaigns aimed at reducing trafficking, and increasing government initiatives. Furthermore, the rising incidence rates of alcohol, cannabis/marijuana, and opioid addiction in Asian countries are expected to further drive market growth in the region.

Drug of Abuse Testing Services Market Trends Key Companies

• Quest Diagnostics
• Abbott
• Clinical Reference Laboratory (CRL), Inc.
• Laboratory Corporation of America Holdings
• Cordant Health Solutions
• Legacy Medical Services
• DrugScan
• Omega Laboratories, Inc.
• Psychemedics Corporation
• Millennium Health, LLC
• Mayo Clinic Laboratories
• Precision Diagnostics
• American Substance Abuse Professionals (ASAP), Inc.
• United States Drug Testing Laboratories (USDTL), Inc.
• LGC Group

Drug of Abuse Testing Services Market Segmentations:

By Drug Type

• Alcohol
• Cannabis/Marijuana
• Cocaine
• Opioids
• Amphetamine & Methamphetamine
• LSD
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Latin America